M&A Deal Summary |
|
|---|---|
| Date | 2016-09-28 |
| Target | Agilux Laboratories |
| Sector | Life Science |
| Buyer(s) | Charles River Laboratories International |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 64M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1947 |
| Sector | Life Science |
| Employees | 20,400 |
| Revenue | 4.1B USD (2023) |
Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 31 |
| Sector (Life Science) | 16 of 28 |
| Type (Add-on Acquisition) | 14 of 26 |
| State (Massachusetts) | 3 of 4 |
| Country (United States) | 11 of 20 |
| Year (2016) | 3 of 3 |
| Size (of disclosed) | 10 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-27 |
Blue Stream Laboratories
Woburn, Massachusetts, United States Blue Stream Laboratories, Inc. is an analytical contract research organization (CRO) supporting the development of complex biologics and biosimilars. Located in Woburn, Massachusetts, the company is recognized for its expertise in structural and functional protein characterization programs, and the development and validation of assays for current good manufacturing practice (cGMP) lot release and stability programs. Protein characterization is the key element for development and registration of biologic and biosimilar entities. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-14 |
QS Pharma
Boothwyn, Pennsylvania, United States QS Pharma, LLC is a provider of a broad range of contract development/research and clinical/commercial manufacturing services for pharmaceutical and biopharmaceutical companies worldwide. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 55 |
| Sector (Life Science) | 13 of 25 |
| Type (Add-on Acquisition) | 22 of 38 |
| State (Massachusetts) | 6 of 14 |
| Country (United States) | 31 of 51 |
| Year (2016) | 9 of 9 |
| Size (of disclosed) | 12 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-08-30 |
Accuratus Lab Services
Eagan, Minnesota, United States Accuratus Lab Services, Inc. is a provider of GMP and GLP testing services to medical device and biopharmaceutical industries to meet FDA standards, as well as EPA regulated antimicrobial and consumer products. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-02-02 |
Corpus Medical
Campbell, California, United States Corpus Medical, Inc. is a provider of high-quality consulting and manufacturing services for the development and commercialization of innovative intervention medical devices. Corpus Medical specializes in catheter technologies, assembly of fully packaged devices and medical implants. Corpus Medical was founded in 2009 and is based in Campbell, California. |
Buy | - |
